206 related articles for article (PubMed ID: 36795945)
41. Obeticholic acid protects mice against lipopolysaccharide-induced liver injury and inflammation.
Xiong X; Ren Y; Cui Y; Li R; Wang C; Zhang Y
Biomed Pharmacother; 2017 Dec; 96():1292-1298. PubMed ID: 29174575
[TBL] [Abstract][Full Text] [Related]
42. Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis.
Modica S; Petruzzelli M; Bellafante E; Murzilli S; Salvatore L; Celli N; Di Tullio G; Palasciano G; Moustafa T; Halilbasic E; Trauner M; Moschetta A
Gastroenterology; 2012 Feb; 142(2):355-65.e1-4. PubMed ID: 22057115
[TBL] [Abstract][Full Text] [Related]
43. JiaGaSongTang improves chronic cholestasis via enhancing FXR-mediated bile acid metabolism.
He X; Zhou Y; Yu J; Huang Q; Chen Z; Xiao R; Liu C; Gui S; Xiong T
Phytomedicine; 2024 Jun; 128():155347. PubMed ID: 38493717
[TBL] [Abstract][Full Text] [Related]
44. Astragalus saponins protect against extrahepatic and intrahepatic cholestatic liver fibrosis models by activation of farnesoid X receptor.
Zhang L; Shi J; Shen Q; Fu Y; Qi S; Wu J; Chen J; Zhang H; Mu Y; Chen G; Liu P; Liu W
J Ethnopharmacol; 2024 Jan; 318(Pt A):116833. PubMed ID: 37400008
[TBL] [Abstract][Full Text] [Related]
45. [Effect of geniposidic acid on hepato-enteric circulation in cholestasis rats through Sirt1-FXR signaling pathway].
Chen H; Li J; Hu L; Zhao W; Yu H; Liu HZ; Ma ST
Zhongguo Zhong Yao Za Zhi; 2019 Feb; 44(4):787-795. PubMed ID: 30989893
[TBL] [Abstract][Full Text] [Related]
46. The Epidermal Growth Factor Receptor Ligand Amphiregulin Protects From Cholestatic Liver Injury and Regulates Bile Acids Synthesis.
Santamaría E; Rodríguez-Ortigosa CM; Uriarte I; Latasa MU; Urtasun R; Alvarez-Sola G; Bárcena-Varela M; Colyn L; Arcelus S; Jiménez M; Deutschmann K; Peleteiro-Vigil A; Gómez-Cambronero J; Milkiewicz M; Milkiewicz P; Sangro B; Keitel V; Monte MJ; Marin JJG; Fernández-Barrena MG; Ávila MA; Berasain C
Hepatology; 2019 Apr; 69(4):1632-1647. PubMed ID: 30411380
[TBL] [Abstract][Full Text] [Related]
47. Modulation of the Unfolded Protein Response by Tauroursodeoxycholic Acid Counteracts Apoptotic Cell Death and Fibrosis in a Mouse Model for Secondary Biliary Liver Fibrosis.
Paridaens A; Raevens S; Devisscher L; Bogaerts E; Verhelst X; Hoorens A; Van Vlierberghe H; van Grunsven LA; Geerts A; Colle I
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117681
[TBL] [Abstract][Full Text] [Related]
48. Molecular mechanisms of hepatotoxic cholestasis by clavulanic acid: Role of NRF2 and FXR pathways.
Petrov PD; Soluyanova P; Sánchez-Campos S; Castell JV; Jover R
Food Chem Toxicol; 2021 Dec; 158():112664. PubMed ID: 34767876
[TBL] [Abstract][Full Text] [Related]
49. Hepatic Autophagy Deficiency Compromises Farnesoid X Receptor Functionality and Causes Cholestatic Injury.
Khambu B; Li T; Yan S; Yu C; Chen X; Goheen M; Li Y; Lin J; Cummings OW; Lee YA; Friedman S; Dong Z; Feng GS; Wu S; Yin XM
Hepatology; 2019 May; 69(5):2196-2213. PubMed ID: 30520052
[TBL] [Abstract][Full Text] [Related]
50. Oleanolic acid attenuates obstructive cholestasis in bile duct-ligated mice, possibly via activation of NRF2-MRPs and FXR antagonism.
Chen P; Li J; Fan X; Zeng H; Deng R; Li D; Huang M; Bi H
Eur J Pharmacol; 2015 Oct; 765():131-9. PubMed ID: 26297978
[TBL] [Abstract][Full Text] [Related]
51. Gardenia extract protects against intrahepatic cholestasis by regulating bile acid enterohepatic circulation.
Qin S; Tian J; Zhao Y; Wang L; Wang J; Liu S; Meng J; Wang F; Liu C; Han J; Pan C; Zhang Y; Yi Y; Li C; Liu M; Liang A
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117083. PubMed ID: 37634748
[TBL] [Abstract][Full Text] [Related]
52. Nuclear factor-E2-related factor 2 is a major determinant of bile acid homeostasis in the liver and intestine.
Weerachayaphorn J; Mennone A; Soroka CJ; Harry K; Hagey LR; Kensler TW; Boyer JL
Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(9):G925-36. PubMed ID: 22345550
[TBL] [Abstract][Full Text] [Related]
53. Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver.
Zollner G; Wagner M; Fickert P; Geier A; Fuchsbichler A; Silbert D; Gumhold J; Zatloukal K; Kaser A; Tilg H; Denk H; Trauner M
Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G798-805. PubMed ID: 16002565
[TBL] [Abstract][Full Text] [Related]
54. Baicalein alleviates intrahepatic cholestasis by regulating bile acid metabolism via an FXR-dependent manner.
Huang W; Qian Y; Lin J; Wang F; Kong X; Tan W
Biochem Biophys Res Commun; 2024 Apr; 705():149670. PubMed ID: 38442444
[TBL] [Abstract][Full Text] [Related]
55. Geniposide attenuates ANIT-induced cholestasis through regulation of transporters and enzymes involved in bile acids homeostasis in rats.
Wang L; Wu G; Wu F; Jiang N; Lin Y
J Ethnopharmacol; 2017 Jan; 196():178-185. PubMed ID: 27988401
[TBL] [Abstract][Full Text] [Related]
56. Sirtuin 1 activation alleviates cholestatic liver injury in a cholic acid-fed mouse model of cholestasis.
Kulkarni SR; Soroka CJ; Hagey LR; Boyer JL
Hepatology; 2016 Dec; 64(6):2151-2164. PubMed ID: 27639250
[TBL] [Abstract][Full Text] [Related]
57. Benefit of farnesoid X receptor inhibition in obstructive cholestasis.
Stedman C; Liddle C; Coulter S; Sonoda J; Alvarez JG; Evans RM; Downes M
Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11323-8. PubMed ID: 16844773
[TBL] [Abstract][Full Text] [Related]
58. Sarmentol H derived from Sedum sarmentosum Bunge directly targets FXR to mitigate cholestasis by recruiting SRC-1.
Liu Z; Chen L; Chen M; Linghu L; Liao Z; Chen M; Wang G
Phytomedicine; 2024 Jul; 130():155759. PubMed ID: 38788394
[TBL] [Abstract][Full Text] [Related]
59. Individual bile acids have differential effects on bile acid signaling in mice.
Song P; Rockwell CE; Cui JY; Klaassen CD
Toxicol Appl Pharmacol; 2015 Feb; 283(1):57-64. PubMed ID: 25582706
[TBL] [Abstract][Full Text] [Related]
60. Gardenia Iridoid Glucosides Protect Against α-Naphthalene Isothiocya-Nate-Induced Cholestatic Rats Through Activation of the FXR-SHP Signaling Pathway.
Xu M; Che K; Wang C; Chen YR; Chen MY; Zhang GL; Yu H; Xu HN; Li YB; Sheng P; Chen H
Clin Exp Gastroenterol; 2023; 16():225-236. PubMed ID: 38090678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
